NCT05771480 2026-03-25
TOURMALINE
AstraZeneca
Phase 3 Active not recruiting
Clinical Trials
3 trialsNCT06109779 2026-03-04
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
Phase 3 Active not recruiting
NCT06490107 2024-07-08
Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting